1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Generic Name | Common Trade Name(s) | Classification | Date Marketed in Canada (yyyy/mm/dd) |
---|---|---|---|
Mirabegron | Myrbetriq | Genitourinary smooth muscle relaxant | 2013/03/28 |
Besifloxacin | Besivance | Fluoroquinolone | 2010/01/27 |
Burosumab | Crysvita | Fibroblast growth factor 23 (FGF23) Inhibitor | 2018/12/05 |
Norethindrone acetate + ethinyl estradiol | femHRT | estrogen-progesterone combination | 2012/10/09 |
Alglucosidase alfa | Myozyme | Enzyme replacement therapy | 2007/04 |
Velaglucerase alfa | Vpriv | Enzyme replacement for treatment of Gaucher disease | 2010/11/22 |
Prucalopride | Resotran | Enterokinetic agent | 2012/01/13 |
Sitaxsentan | Thelin | Endothelin receptor antagonist | |
Sacubitril + valsartan | Entresto | Endopeptidase inhibitor, angiotension II receptor antagonist | 2015/11/13 |
Upadacitinib | Rinvoq | Disease-modifying antirheumatic agent | 2020/01/16 |
Sarilumab | Kevzara | Disease modifying anti-rheumatic drug | 2017/08/16 |
Saxagliptin | Onglyza | Dipeptidyl peptidase-4 inhibitor; Incretin enhancer | 2009/09/14 |
Ivacaftor | Kalydeco | Cystic fibrosis transmembrane conductance regulator potentiator | 2012/12/01 |
Ivacaftor + tezacaftor | Symdeko | Cystic Fibrosis Transmembrane Conductance Regulator Correctors and Potentiators | 2018/06/27 |
Elexacaftor + tezacaftor + ivacaftor | Trikafta | Cystic fibrosis transmembrane conductance regulator correctors | 2021/06/22 |
Lumiracoxib | Prexige | COX-2 inhibitor | 2006/11 |
Mometasone + formoterol | Zenhale | Corticosteroid + long-acting beta2- agonist | 2011/02/01 |
Loteprednol etabonate | Lotemax | Corticosteroid | 2009/01 |
Desonide | Verdeso | Corticosteroid | 2011/04/20 |
Mometasone | Asmanex Twisthaler | Corticosteroid | 2011/12/22 |
Dexamethasone | Ozurdex | Corticosteroid | 2012/01/19 |
Levonorgestrel | Backup Plan Onestep | Contraceptive agent | 2016/01/28 |
Ulipristal acetate | Ella | Contraceptive | 2015/09/01 |
Abatacept | Orencia | Co-stimulation modulator for rheumatoid arthritis | 2006/09 |
Lisdexamfetamine | Vyvanse | CNS stimulant | 2010/04/20 |
Flibanserin | ADDYI | CNS agent | 2018/02/27 |
Galcanezumab | Emgality | CGRP binding antibody | 2019/10/02 |
Tadalafil | Adcirca | cGMP-specific phosphodiesterase type 5 inhibitor | 2009/11/25 |
Sildenafil citrate | Revatio IV | cGMP-Specific Phosphodiesterase Type 5 Inhibitor | 2010/08/31 |
Ceftobiprole medocaril | Zeftera | Cephalosporin antibiotic | 2010/04/16 |
Cefotaxime | Claforan | Cephalosporin antibiotic | 2016/11/09 |
Ceftobiprole | Zevtera | Cephalosporin antibiotic | 2018/03/20 |
Voretigene | Luxturna | Cellular and gene therapy | 2020/10/13 |
Onasemnogene | Zolgensma | Cellular and gene therapy | 2021/02/04 |
Ivabradine | Lancora | Cardiac medication | 2017/04 |
C1 esterase inhibitor, human | Berinert | C1-inhibitor | 2010/10/08 |